Prenetics Global Ltd. (PRE) Wednesday announced a narrower loss for the third quarter as revenues surged 59.4 percent from the prior year.
Quarterly loss for the health sciences company was $12.06 million, narrower than $14.08 million a year ago.
On a per share basis, loss was $0.84, compared to $0.88 last year.
Revenue for the quarter increased to $7.78 million from $4.88 million in the prior year
Further, Prenetics reiterated its revenue target to exceed $33 million for the full year 2024.
For comments and feedback: editorial@rttnews.com